Advertisement

Pharmaceutisch weekblad

, Volume 3, Issue 1, pp 876–879 | Cite as

Serumbinding en ziekteprocessen

  • F. M. Belpaire
Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatuur

  1. Andreasen, F. (1974)Acta Pharmacol. Toxicol. 34, 284–294.CrossRefGoogle Scholar
  2. Bachmann, K., enR. Shapiro (1977)Clin. Pharmacokin. 2, 110–126.CrossRefGoogle Scholar
  3. Belpaire, F.M., M.G. Bogaert, M. Rosseneu enO. Teirlynck (1981)Brit. J. Clin. Pharmacol., 11, 125P-126P.Google Scholar
  4. Blaschke, T.F. (1977)Clin. Pharmacokin. 2, 32–44.CrossRefGoogle Scholar
  5. Boobis, S.W. (1977)Clin. Pharmacol. Therap. 22, 147–153.CrossRefGoogle Scholar
  6. Borga, O. (1979)Advances in Pharmacology and Therapeutics. Vol. 7. Pergamon Press, Oxford, 143.Google Scholar
  7. Chakrabarti, S.K., R. Laliberte enJ. Brodeur (1976)Biochem. Pharmacol. 25, 2515–2521.CrossRefPubMedGoogle Scholar
  8. Craig, W.A., M.A. Evenson, K.P. Sawer enJ.P. Wagnild (1976)J. Lab. Clin. Med. 87, 637–647.PubMedGoogle Scholar
  9. Danon, A., enZ. Chen (1979)Clin. Pharmacol. Therap. 25, 316–321.CrossRefGoogle Scholar
  10. Dromgoole, S.H. (1977)J. Pharmacol. Exp. Therap. 191, 318–323.Google Scholar
  11. Fremstad, D., K. Bergerud, J.F.W. Haffner enP.K.W. Lunde (1976)Europ. J. Clin. Pharmacol. 10, 441–411.CrossRefGoogle Scholar
  12. Goodmann, W.S. (1958)J. Am, Chem. Soc. 80, 3892–3898.CrossRefGoogle Scholar
  13. Gugler, R., enD.L. Azarnoff (1976)Clin. Pharmacokin. 1, 25–35.CrossRefGoogle Scholar
  14. Kates, R.E., T.D. Sokoloski enT.J. Comstock (1978)Clin. Pharmacol. Therap. 23, 30–35.CrossRefGoogle Scholar
  15. Mussche, M.M., F.M. Belpaire enM.G. Bogaert (1975)Europ. J. Clin. Pharmacol., 9, 69–71.CrossRefGoogle Scholar
  16. Nilsen, O.G. (1976)Biochem. Pharmacol. 25, 1007–1012.CrossRefPubMedGoogle Scholar
  17. Odar-Cederlöf, I. (1977)Clin. Pharmacokin. 2, 147–153.CrossRefGoogle Scholar
  18. Piafsky, K. (1980)Clin. Pharmacokin. 5, 246–262.CrossRefGoogle Scholar
  19. Piafsky, K., O. Borga, I. Odar-Cederlöf, C. Johansson enF. Sjoqvist (1978)New Engl. J. Med. 299, 1435–1439.CrossRefPubMedGoogle Scholar
  20. Reidenberg, M.M. (1976)Clin. Pharmacokin. 1, 121–125.CrossRefGoogle Scholar
  21. Routledge, P.A., W.W. Stargel, G.S. Wagner enD.G. Shand (1980)Brit. J. Clin. Pharmacol. 9, 438–439.CrossRefGoogle Scholar
  22. Schneider, R.E., H. Bishop enC.F. Hawkins (1979)Brit. J. Clin. Pharmacol. 8, 43–47.CrossRefGoogle Scholar
  23. Shoeman, D.W., enD.L. Azarnoff (1972)Pharmacology 7, 169–177.CrossRefPubMedGoogle Scholar
  24. Sjöholm, I., A. Kober, I. Odar-Cederlöf enO. Borga (1976)Biochem. Pharmacol. 25, 1205–1213.CrossRefPubMedGoogle Scholar
  25. Storstein, L. (1976)Clin. Pharmacol. Therap. 20, 15–23.CrossRefGoogle Scholar
  26. Tillement, J.P., F. Lhoste enJ.F. Giudicelli (1978)Clin. Pharmacokin. 3, 144–154.CrossRefGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1981

Authors and Affiliations

  • F. M. Belpaire
    • 1
  1. 1.J. F. & C. Heymans Instituut voor Farmakodynamie en Terapie der RijksuniversiteitGentBelgië

Personalised recommendations